combined findings have demonstrated that high plasma ANP and BNP concentrations may reflect the degree of left ventricular dysfunction or a poor prognosis in patients with CHF. In addition, it has been postulated that the magnitude of exercise-induced ANP or BNP secretion may be influenced by the sympathetic nervous system. 14 In regard to these reports, the measurement of circulating ANP and BNP may be a sensitive measure for detecting left ventricular dysfunction or a poor prognosis in cardiac patients. However, little is known about changes in plasma ANP and BNP concentrations during commonly occurring physiological states such as fatigue. The aim of the present study was to clarify whether plasma ANP and BNP concentrations are affected by chronic fatigue, using a model of chronic sleep deprivation. In addition, plasma norepinephrine (NE) concentration, exercise tolerance, and cardiac output (CO) during exercise were measured and compared with changes in ANP and BNP concentrations.
Methods
The subjects of this study consisted of 10 healthy male volunteers (college students whose mean age was 22.8±1.2 years). All subjects had no past history of serious disease. Their present health status was checked by routine physical examination, chest X-ray, resting ECG, and routine laboraJpn Circ J 1999; 63: 447 -452 (Received January 8, 1999 ; revised manuscript received March 3, 1999 ; accepted March 9, 1999 Recent observations have shown that plasma levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) correlate with cardiac function or prognosis in heart failure patients. However, relatively little is known about changes in their plasma concentration during commonly occurring physiological states such as fatigue. Therefore, this study was designed to examine the physiological changes of plasma ANP and BNP concentrations using a chronic sleep-deprivation model. Bicycle ergometer cardiopulmonary exercise tests were performed in 10 healthy volunteers (mean age: 22.7 years). Blood samples for measuring ANP and BNP were drawn during the resting state and immediately after each exercise test. Cardiac output (CO) was measured during the exercise test by the impedance method. The study conditions were designed as follows: (A) a day following a period of normal sleep (control state) and (B) a day preceded by 1 month during which sleep lasted <60% of normal (chronic sleep-deprived state). Results were as follows. (1) Peak oxygen uptake and peak CO decreased during the sleep-deprived state compared with the control state. (2) There was no difference between peak heart rates measured during exercise under the 2 conditions. (3) Plasma ANP concentration during exercise increased significantly during the control state, whereas only a tendency toward increase was observed during the sleep-deprived state. (4) Plasma BNP concentration during exercise tended to increase in the control state compared with the resting state, whereas there was no difference in plasma BNP between after exercise and resting state in the sleep-deprived state. These results indicate that changes of ANP or BNP induced by exercise tended to be decreased by chronic sleep deprivation. (Jpn Circ J 1999; 63: 447 -452) Key Words: Atrial natriuretic peptide; Brain natriuretic peptide; Exercise tolerance; Sleep deprivation tory examinations, of which all were within normal limits. Test conditions were as follows: (A) control state: a day following 2 weeks of good sleep; (B) chronically sleepdeprived state: a day preceded by 1 month during which sleep lasted less than 60% of that in condition A because the subjects were studying for an examination.
After completion of the cardiopulmonary exercise test in the control state, all subjects entered the 1-month sleepdeprived state. No restrictions other than a prohibition of alcohol ingestion were imposed on the daily lives of the subjects. The hours of sleep during each condition were ascertained by an interview questionnaire.
According to the protocol approved by the Committee on Human Investigation at St Marianna University School of Medicine, written informed consent for participation in this study was obtained from all subjects before the study.
Methods of Cardiopulmonary Exercise Testing
Symptom-limited cardiopulmonary exercise tests were performed using the ramp protocol with a bicycle ergometer (1 W/3 s) to measure anaerobic threshold (AT), exercise time from beginning the ramp exercise test until AT was attained (AT time), peak oxygen uptake (peak V • O2), and peak exercise time. After a 4-min rest on the bicycle ergometer, exercise began with a 4-min warm-up (20 W) followed by an increase in load (1 W/3 s). Subjects were monitored by a 12-lead ECG during exercise testing, and heart rate (HR), ST-T change, and arrhythmia were carefully noted. Blood pressure was measured at 1-min intervals by a cuff method. V
• O2, carbon dioxide production (V • CO2), and minute ventilation (V • E) were measured throughout using a RM-300 respiration monitor and a MG-360 gas analyzer (Minato Ikagaku Co, Tokyo, Japan). The measurement system for cardiopulmonary exercise testing was calibrated before starting each study. Expired gas was sampled using a breath-by-breath technique.
From these measurements, the ventilatory equivalents were calculated for O2 by V
• E/V • O2, and for CO2 by V
• E/V • CO2, and the gas exchange ratio was determined by V
• CO2/V • O2. These calculations were made by using a personal computer (NEC PC-9801).
AT was determined by the following conventional criteria: 15 (1) V
• E/V • O2 increased after being constant or decreasing, while V
• E/V • CO2 remained constant or decreased, and (2) the gas exchange ratio started to increase steeply. Blood samples for determining the plasma concentration of ANP, BNP, and NE were drawn after 30 min of rest and immediately after the exercise test.
Measurement of CO
Measurement of CO during the exercise test was performed by thoracic bioimpedance using an NCCOM3-R7 cardiac output monitor (Bomed Medical Instruments, Irvine, CA, USA). Thoracic bioimpedance measured the pulsatile change in resistance to injected microcurrents to calculate stroke volume. Four pairs of disposable electrodes were placed on the neck and chest. The outer pairs of electrodes directed a 70-kHz, 2.5-mA current into the thoracic tissue and the current was then sent with the inner pairs of electrodes. The resistance to the current was dependent upon the fluid characteristics of the thoracic volume. CO was measured on a beat-by-beat basis, and was represented as the average of 16 accepted beats. The exerciseinduced change in CO was calculated as ∆CO = (peak value) -(resting value).
Measurement of Plasma ANP, BNP, and NE Concentrations
For the measurement of plasma ANP and BNP concentrations, 5 ml of venous blood was drawn from the cubital vein and immediately aspirated into a polypropylene tube containing 4.5 mg of EDTA-2Na and 150 l of tradirol. The sampled blood was immediately ice-cooled and centrifuged at 3000 rpm for 10 min at 4°C, thereby separating the plasma, which was maintained in frozen storage at -70°C until needed for analysis. Plasma ANP concentration was measured by a radio-immunoassay, and plasma BNP concentration was measured by an immunoradiometric assay (Shionoria BNP, Osaka, Japan) using 2 monoclonal antibodies.
The plasma concentration of NE was analyzed with high-performance liquid chromatography using blood samples that had been collected in polypropylene tubes containing EDTA, centrifuged at 3000 rpm for 10 min and the plasma extracted.
All data are expressed as the mean value ± SD. Differences between the control state and sleep-deprived state or between the resting value and the value after exercise were evaluated by Fisher's PLSD after an initial evaluation by one-way analysis of variance. A value of p<0.05 was considered significant, and a value of p<0.1 was considered as showing a tendency toward significance. (Table 1) For all subjects, the endpoint of the exercise test was leg fatigue or shortness of breath. No subjects experienced ischemic ST change or severe arrhythmia. The mean values of AT, AT time, and peak V
Results

Temporal Changes in Exercise Tolerance
• O2 in the chronically sleepdeprived state were significantly lower than those in the control state. There was no significant difference in peak exercise time between the control and chronically sleepdeprived states. There was no significant difference in blood pressure at rest, at AT, or at peak exercise between the control state and the chronic sleep-deprived state.
Temporal Changes in CO
The mean values of CO at rest were 5.8±1.2 L/min in the control state and 5.9±1.1 L/min in the chronic sleepdeprived state. Fig 1 shows the peak CO and ∆CO during exercise testing in 8 subjects who were evaluated completely. The mean CO level at peak exercise was significantly lower (p<0.05) during chronic sleep deprivation than during normal sleep (23.9±4.2 and 26.4±3.4 L/min, respectively). The mean value of ∆CO also was significantly lower (p<0.05) during chronic sleep deprivation than during normal sleep (17.9±3.5 and 20.6±2.8 L/min, respectively).
Temporal Changes in ANP and BNP Concentration During Exercise
ANP concentration increased significantly after exercise testing in the control state (from 8.3±4.4 to 15.6±11.0 pg/ml), whereas only a tendency toward increase was found in chronic sleep deprivation (from 5.2±0.7 to 9.2±5.1 pg/ml) (Fig 2) . The BNP concentration tended to increase after exercise testing in the control state (from 5.5±2.7 to 9.1±6.2 pg/ml), whereas there was no significant difference in BNP between the resting state and peak exercise during the chronic sleep-deprived state (4.0±0.0 vs 4.3±0.9 pg/ml) (Fig 3) .
In comparing plasma ANP and BNP concentration between the control and sleep-deprived states, plasma ANP concentration immediately after exercise in the sleepdeprived state tended to be low compared with the control state (p<0.1). There was no significant difference between the 2 conditions with respect to plasma ANP at the resting state and plasma BNP concentration.
Temporal Changes in NE Concentration
Resting NE concentrations in the control state and during the chronically sleep-deprived state were 250.2± 64.2 pg/ml and 372.7±115.3 pg/ml (p<0.05), respectively. The corresponding NE concentrations at peak exercise were 3432.5±1538.3 pg/ml and 3842.3±1498.1 pg/ml (not significant).
Correlation Between ANP or BNP Concentration and NE, HR and CO (Fig 4)
Plasma ANP concentration at peak exercise showed a tendency toward a positive correlation with peak NE concentration (r=0.43, p<0.1). However, plasma ANP concentration at peak exercise had no correlation with peak HR, peak CO, or ∆CO. No correlation was observed between BNP concentration and peak NE concentration, peak HR, peak CO, or ∆CO.
Discussion
In previous studies, plasma ANP concentration correlated closely with pulmonary wedge pressure, 1 HR, 2 or plasma NE concentration, 14 and the plasma BNP level seemed to reflect the degree of left ventricular dysfunction. 13 Clinical studies have documented plasma ANP and BNP concentration increases in response to exercise in healthy subjects, 14 as well as in hypertensive subjects and patients with CHF. 8, 9 High concentrations of these peptides are also considered to indicate left ventricular dysfunction or poor prognosis in patients with CHF. However, it is not clear whether these plasma concentrations are affected by changes in physiological conditions such as chronic sleep deprivation. In the present study, we compared plasma ANP and BNP responses to exercise in subjects during chronic sleep deprivation and during a normal control state.
Relationship Between Plasma ANP and BNP Concentrations and Cardiac Function
Matsumoto et al compared plasma levels of ANP and BNP at rest and during bicycle exercise in patients with dilated cardiomyopathy or mitral stenosis. 16 In that study, the severity of heart failure in terms of symptoms and resting hemodynamics, such as atrial pressure, was similar in both groups; however, the patients with dilated cardiomyopathy had a higher left ventricular end-diastolic pressure and a lower left ventricular ejection fraction than those with mitral stenosis. The patients with dilated cardiomyopathy also had higher plasma BNP levels at rest and during exercise than the patients with mitral stenosis, Fig 4 . Correlation between ANP concentration and norepinephrine concentration or heart rate. Plasma ANP concentration at peak exercise showed a tendency toward positive correlation with norepinephrine concentration. However, plasma ANP concentration at peak exercise had no relationship with peak HR. ANP, atrial natriuretic peptide; NE, norepinephrine; HR, heart rate.
although there was no difference in their plasma ANP levels. The authors concluded that the increased secretion of BNP may originate from pressure and volume overload of the left ventricle or from ventricular stretch, which is one of the most important stimuli for the release of BNP. Yokoyama et al investigated changes in plasma BNP level during exercise and serial plasma BNP changes in patients during the recovery phase of myocardial infarction. 17 Plasma BNP level increased significantly following exercise at both 1 and 3 months after infarction onset. Morita et al reported that BNP secretion from the left ventricle increased after the occurrence of myocardial infarction and that its plasma level could reflect the degree of left ventricular dysfunction by the negative correlation between the ejection fraction and BNP concentration and by the positive correlation between left ventricular end-diastolic pressure and BNP secretion. 12 Our present study revealed that exercise-raised plasma levels of ANP and BNP associated with chronic sleep deprivation were lower than those associated with normal sleep, although there was no difference with regard to peak HR or peak exercise time. Peak CO during exercise testing following chronic sleep deprivation was significantly lower than its level following normal sleep, whereas there was no difference with regard to peak blood pressure between the control and chronically sleepdeprived state. From the viewpoint of CO and blood pressure, Sagawa reported a schematic expression of the timevarying CO surface as a 3-dimensional surface in the mean blood pressure-right atrial pressure-CO. 18 In applying the present results to this time-varying CO surface, it is feasible to surmise that right atrial pressure during exercise in chronic sleep deprivation is as low as that in the control state. Osada tested cardiopulmonary function in the chronic sleep-deprived state using the same model of chronic sleep deprivation. 19 In that study, left ventricular diastolic dimension at rest in the chronic sleep-deprived state measured by echocardiography was less than that in the control state; this difference was not statistically significant. In the present study, the resting HR in the chronic sleep-deprived state was significantly higher than that in the control state. Taking all these findings into account, our results may support the hypothesis that pulmonary capillary wedge pressure and pressure or volume overload of the left ventricle during exercise are low in subjects with chronic sleep deprivation compared with normal sleep. This seems to be a possible explanation for why changes in plasma ANP and BNP concentrations during exercise are less in subjects with chronic sleep deprivation than in those with normal sleep.
Relationship Between Plasma ANP or BNP Concentration and Sympathetic Stimulation
Hirsch et al reported that plasma levels of both ANP and vasoconstrictor neurohormones are increased in patients with CHF. 20 Plasma ANP level correlated directly with the concentration of vasoconstrictor hormones such as plasma NE, epinephrine, angiotensin II, and vasopressin. Hirsch et al suggested that ANP is a relatively weak counterregulatory hormone against vasoconstrictor neurohormones in CHF. Cody et al also reported an exercise-induced increase in plasma ANP associated with increased plasma NE level. 21 In the present study, plasma ANP level showed a tendency toward direct correlation with plasma NE concentration, even in the healthy male, a finding that agrees with the report of Hirsch et al. In normotensive subjects, the exercise-induced release of BNP showed a similar response to that of ANP, but a slightly different response to sympathetic stimuli. 14 In the present study, no significant exerciseinduced increases in plasma BNP concentration were observed following chronic sleep deprivation, although significant increases were observed with respect to plasma NE concentration. Under both conditions tested in this study, the plasma BNP concentration at peak exercise did not correlate with increases in NE or with peak HR. Our results, therefore, are incompatible with the results of the relation between BNP concentration and NE level. Pressure and volume overload of the left ventricle may be one of the most important stimuli for the release of BNP, but not the NE level in healthy subjects. In summary, there seems to be no correlation between plasma BNP concentration and sympathetic stimuli associated with chronic sleep deprivation in healthy subjects.
Clinical Implication of the Study
These results support the hypothesis that a clinical evaluation of left ventricular dysfunction, which uses the values of plasma ANP or BNP concentration to estimate the degree of dysfunction, could underestimate the dysfunction if the subject is in a state of chronic sleep deprivation.
Study Limitations
In the present study, hemodynamic monitoring such as pulmonary wedge pressure or left ventricular end-diastolic pressure and evaluation of extracellular fluid volume were not performed. Mechanisms of decrease in exerciseinduced changes of plasma ANP or BNP concentration will be the subject of further study including evaluation of actual left ventricular function, peripheral venous function, and extracellular fluid volume during chronic sleep deprivation.
Conclusion
Exercise-induced changes of plasma ANP or BNP concentration are decreased due to chronic sleep deprivation.
